Form 8-K - Current report:
SEC Accession No. 0001619856-25-000002
Filing Date
2025-01-02
Accepted
2025-01-02 08:03:14
Documents
16
Period of Report
2025-01-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crbu-20250102.htm   iXBRL 8-K 34838
2 EX-99.1 crbu-20250102xexx991.htm EX-99.1 12766
6 high-resxsrixryalix123024a.jpg GRAPHIC 364137
7 img25401123_0a.jpg GRAPHIC 52289
  Complete submission text file 0001619856-25-000002.txt   754800

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crbu-20250102.xsd EX-101.SCH 1791
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crbu-20250102_lab.xml EX-101.LAB 23449
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crbu-20250102_pre.xml EX-101.PRE 13587
18 EXTRACTED XBRL INSTANCE DOCUMENT crbu-20250102_htm.xml XML 2916
Mailing Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710
Business Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710 510-982-6030
Caribou Biosciences, Inc. (Filer) CIK: 0001619856 (see all company filings)

IRS No.: 453728228 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40631 | Film No.: 25500279
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)